SPOM

 
Common Stock Alternative Reporting
Pink Current Information
 

OTC Disclosure & News Service

 

Another Great Customer Win

Apr 21, 2017

OTC Disclosure & News Service

Woburn, MA -

Another Great Customer Win

 

 

To All Shareholders:  Woburn / 21 April, 2017.

 

We are pleased to inform all our shareholders that the company has received its first purchase order from a large Public Utilities company in the United States to provide Software and Professional Consulting Services using our flagship technology StressTester for IBM Maximo.  The first order is for the software element of the project with further orders in the pipeline for the consultancy work, which will consist of system set up and development services, giving the company an ongoing revenue stream. 

 

This new customer adds to our growing and impressive list of enterprise customers across a broad range of industries and government services.

 

After a fantastic first quarter, we are looking forward to the coming months and securing more of the business from our growing sales pipeline.  We have verbal commitment on 2 large deals in the United Kingdom, one for a large European Energy Company the other for a large Engineering firm who provides a portfolio of services to the building and engineering maintenance sector.  We hope to bring you more news on these in the coming weeks.

 

 

Once again, we are very pleased you can be a part of our future success.

 

 

Owen Dukes

 

 

This shareholder letter contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, expectations regarding the successful expansion of our product base, profitability, market acceptance of our products and new product applications, timing of new product launches, product performance, size of prospective markets, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans, patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us. We undertake no obligation to revise or update any forward-looking statement for any reason. 

 

 

 

This release includes additional documents. Select the link(s) below to view.

SPO Global  Shareholder Ltter 21 April 2017.pdf

Copyright © 2017 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.